Reducing CRC risk should always be discussed with patients, expert says ...

Hispanic patients with inflammatory bowel disease (IBD) have varying disease patterns depending on their genetic ancestry, ...

Patients with inflammatory bowel disease and precancerous colorectal lesions face an increased risk of developing colorectal cancer, with risk levels tied to the severity of the lesions, according to ...

Precancerous colorectal lesions, or dysplasia, in patients with inflammatory bowel disease (IBD) confer markedly different risks of future colorectal cancer depending on dysplasia grade, according to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients with IBD had an increased risk for venous ...

NImmune Biopharma ("NImmune"), a private late-stage precision inflammation and immunology ("I&I") biopharmaceutical company, today announced that Executive Chairman, President and CEO Dr. Josep ...

Teva Pharmaceutical Industries Limited TEVA shares are higher during Tuesday’s premarket session as the company is discussing ...

VIENNA — Researchers have determined a bidirectional relationship between inflammatory bowel disease (IBD) and type 1 diabetes (T1D), using both a cohort and case-control approach to analysis. Their ...

GLP-1 receptor agonists offer more than weight loss for patients with inflammatory bowel disease, with markedly improved ...

Research led by a Houston Methodist gastroenterologist shows that patients who have inflammatory bowel disease (IBD) for more than two decades have a higher risk of developing nonalcoholic fatty liver ...

Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s ...